D. Damek

Alliance A071401: Phase II Trial of Focal Adhesion Kinase Inhibition in Meningiomas With Somatic NF2 Mutations

Mark D Anderson, Jennie W. Taylor, Mark D. Anderson, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

280O Pharmacokinetics and pharmacodynamics of paxalisib in newly diagnosed glioblastoma patients with unmethylated MGMT promoter status: Final phase II study results

J. D. de Groot, J. Battiste, B. Ellingson, 2022, Annals of Oncology.